Clinical Trial Designs in PAH: Shifting From Functional Measurements to Long-term Clinical Outco
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
4
5 Things to Know About the Oral GLP-1 Era
5
